Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises PT to $64.

viernes, 6 de febrero de 2026, 1:47 pm ET1 min de lectura
BMY--

Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises PT to $64.

Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises PT to $64.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios